Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria

Mark Charbonneau et al. develop a mathematical model that describes the behavior of an engineered bacterial therapeutic, SYNB1618, in the human gastrointestinal tract and its effects on plasma phenylalanine (Phe) levels. This model enables the authors to predict plasma Phe lowering by SYNB1618 in pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mark R. Charbonneau, William S. Denney, Nicholas G. Horvath, Pasquale Cantarella, Mary J. Castillo, Marja K. Puurunen, Aoife M. Brennan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/9c842b6d19dd4ea5ab162237138ababd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!